BioNTech SE (BNTX) Current Leases (2021 - 2024)

BioNTech SE has disclosed Current Leases across 4 years of filings, most recently posting $42.2 million for Q4 2024.

• Current Leases for Q4 2024 came in at $42.2 million, up 39.61% year-over-year; the trailing twelve-month figure through Dec 2024 was $42.2 million (up 39.61% YoY), and the FY2024 annual result was $42.2 million, up 39.61% from the prior year.
• Current Leases came in at $42.2 million for Q4 2024 at BioNTech SE, up from $30.2 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $42.2 million in Q4 2024 to a low of $30.2 million in Q4 2023.
• The 4-year median for Current Leases is $34.3 million (2021), against an average of $35.3 million.
• Across the five-year window, Current Leases slipped 17.68% in 2023 and soared 39.61% in 2024, its largest moves.
• BioNTech SE's Current Leases stood at $31.9 million in 2021, then gained by 15.08% to $36.7 million in 2022, then retreated by 17.68% to $30.2 million in 2023, then surged by 39.61% to $42.2 million in 2024.
• The last three Current Leases figures came in at $42.2 million (Q4 2024), $30.2 million (Q4 2023), and $36.7 million (Q4 2022), per Business Quant data.